nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM3—nephrolithiasis	0.928	1	CbGaD
Methylscopolamine bromide—CHRM5—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00918	0.17	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—ureter—nephrolithiasis	0.00854	0.865	CbGeAlD
Methylscopolamine bromide—CHRM1—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00647	0.12	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Muscarinic acetylcholine receptors—CHRM3—nephrolithiasis	0.00638	0.118	CbGpPWpGaD
Methylscopolamine bromide—Tiotropium—CHRM3—nephrolithiasis	0.00221	0.253	CrCbGaD
Methylscopolamine bromide—CHRM5—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00203	0.0375	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00171	0.0316	CbGpPWpGaD
Methylscopolamine bromide—Scopolamine—CHRM3—nephrolithiasis	0.0015	0.172	CrCbGaD
Methylscopolamine bromide—CHRM1—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00143	0.0264	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00141	0.0261	CbGpPWpGaD
Methylscopolamine bromide—Hyoscyamine—CHRM3—nephrolithiasis	0.00138	0.158	CrCbGaD
Methylscopolamine bromide—Homatropine Methylbromide—CHRM3—nephrolithiasis	0.0013	0.149	CrCbGaD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.00124	0.023	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0012	0.0222	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00119	0.0219	CbGpPWpGaD
Methylscopolamine bromide—Atropine—CHRM3—nephrolithiasis	0.00117	0.134	CrCbGaD
Methylscopolamine bromide—Ipratropium bromide—CHRM3—nephrolithiasis	0.00116	0.133	CrCbGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000876	0.0162	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000873	0.0162	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—RGS14—nephrolithiasis	0.000865	0.016	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000701	0.013	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—renal system—nephrolithiasis	0.000679	0.0687	CbGeAlD
Methylscopolamine bromide—CHRM3—kidney—nephrolithiasis	0.000656	0.0665	CbGeAlD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000627	0.0116	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Other—CHRM3—nephrolithiasis	0.000627	0.0116	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000608	0.0112	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000608	0.0112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—RGS14—nephrolithiasis	0.000601	0.0111	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000507	0.00937	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000493	0.00913	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—DGKH—nephrolithiasis	0.000492	0.0091	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000453	0.00838	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.000441	0.00816	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00044	0.00814	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000428	0.00791	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000428	0.00791	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Calcium Regulation in the Cardiac Cell—CHRM3—nephrolithiasis	0.000422	0.00781	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Regulation of Actin Cytoskeleton—CHRM3—nephrolithiasis	0.000422	0.00781	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000392	0.00724	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.000357	0.0066	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000336	0.00621	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.000319	0.0059	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—RGS14—nephrolithiasis	0.000296	0.00547	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000276	0.0051	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.000272	0.00504	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—RGS14—nephrolithiasis	0.000268	0.00497	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—CHRM3—nephrolithiasis	0.000255	0.00473	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000236	0.00437	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—PTH—nephrolithiasis	0.000234	0.00432	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000233	0.00431	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—RGS14—nephrolithiasis	0.000208	0.00385	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—RGS14—nephrolithiasis	0.000208	0.00384	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—RGS14—nephrolithiasis	0.000205	0.0038	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DGKH—nephrolithiasis	0.0002	0.00369	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—RGS14—nephrolithiasis	0.000189	0.0035	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—RGS14—nephrolithiasis	0.000188	0.00349	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—RGS14—nephrolithiasis	0.000187	0.00345	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADCY10—nephrolithiasis	0.000187	0.00345	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DGKH—nephrolithiasis	0.000181	0.00336	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—CHRM3—nephrolithiasis	0.00018	0.00333	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—CHRM3—nephrolithiasis	0.000178	0.00329	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—PTH—nephrolithiasis	0.000165	0.00304	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—PTH—nephrolithiasis	0.000164	0.00303	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—PTH—nephrolithiasis	0.000162	0.003	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RGS14—nephrolithiasis	0.000159	0.00293	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000144	0.00267	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DGKH—nephrolithiasis	0.000141	0.0026	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DGKH—nephrolithiasis	0.00014	0.00259	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DGKH—nephrolithiasis	0.000139	0.00257	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—GRHPR—nephrolithiasis	0.000133	0.00246	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—PTH—nephrolithiasis	0.000132	0.00244	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADCY10—nephrolithiasis	0.000131	0.00243	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—CHRM3—nephrolithiasis	0.000131	0.00243	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADCY10—nephrolithiasis	0.000131	0.00242	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADCY10—nephrolithiasis	0.00013	0.0024	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DGKH—nephrolithiasis	0.000128	0.00236	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DGKH—nephrolithiasis	0.000127	0.00235	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DGKH—nephrolithiasis	0.000126	0.00233	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—PTH—nephrolithiasis	0.00012	0.00222	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AGXT—nephrolithiasis	0.000119	0.0022	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RGS14—nephrolithiasis	0.000112	0.00207	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RGS14—nephrolithiasis	0.000111	0.00206	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RGS14—nephrolithiasis	0.00011	0.00204	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DGKH—nephrolithiasis	0.000107	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000107	0.00198	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000102	0.00188	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SLC26A1—nephrolithiasis	0.000101	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—APRT—nephrolithiasis	0.000101	0.00187	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—CHRM3—nephrolithiasis	0.0001	0.00186	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—PTH—nephrolithiasis	9.3e-05	0.00172	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—PTH—nephrolithiasis	9.27e-05	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—CHRM3—nephrolithiasis	9.23e-05	0.00171	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—PTH—nephrolithiasis	9.18e-05	0.0017	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—CHRM3—nephrolithiasis	9.11e-05	0.00169	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—PTH—nephrolithiasis	8.44e-05	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—PTH—nephrolithiasis	8.42e-05	0.00156	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—PTH—nephrolithiasis	8.34e-05	0.00154	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—CHRM3—nephrolithiasis	7.75e-05	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.54e-05	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DGKH—nephrolithiasis	7.54e-05	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DGKH—nephrolithiasis	7.52e-05	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.52e-05	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ATP6V0A4—nephrolithiasis	7.45e-05	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DGKH—nephrolithiasis	7.45e-05	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—AQP1—nephrolithiasis	7.19e-05	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—PTH—nephrolithiasis	7.08e-05	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—CHRM3—nephrolithiasis	5.45e-05	0.00101	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—CHRM3—nephrolithiasis	5.38e-05	0.000996	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—PTH—nephrolithiasis	4.99e-05	0.000923	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—PTH—nephrolithiasis	4.97e-05	0.00092	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—PTH—nephrolithiasis	4.92e-05	0.000911	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—SPP1—nephrolithiasis	3.56e-05	0.000658	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—SPP1—nephrolithiasis	2.5e-05	0.000463	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—SPP1—nephrolithiasis	2.5e-05	0.000462	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—SPP1—nephrolithiasis	2.47e-05	0.000457	CbGpPWpGaD
